Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Myeloid 1Classical hematology 1

Conditions

Multiple Myeloma 9Leukemia, Lymphocytic, Chronic, B-Cell 6Hodgkin Disease 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Myelodysplastic Syndromes 5Primary Myelofibrosis 4Neoplasms, Plasma Cell 4Lymphoma, Non-Hodgkin 4Lymphoma, Mantle-Cell 4Lymphoma, Follicular 4Lymphoma, B-Cell, Marginal Zone 4Lymphoma 4Leukemia, Myeloid, Acute 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Myeloproliferative Disorders 3Lymphoma, Large B-Cell, Diffuse 3Leukemia 3Graft vs Host Disease 3Burkitt Lymphoma 3Recurrence 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large-Cell, Anaplastic 2Leukemia, Myelomonocytic, Juvenile 2Leukemia, Myelomonocytic, Chronic 2Anemia, Aplastic 2Waldenstrom Macroglobulinemia 1Thrombocytopenia 1Thrombocythemia, Essential 1Precancerous Conditions 1

Interventions

Epoetin Alfa 10Darbepoetin alfa 4Therapeutics 2Filgrastim 2Ferric Oxide, Saccharated 2Cyclophosphamide 2Busulfan 2venetoclax 1trametinib 1ruxolitinib 1reolysin 1regorafenib 1ponatinib 1pertuzumab 1pembrolizumab 1palbociclib 1olaparib 1neratinib 1lorlatinib 1lenvatinib 1idelalisib 1fludarabine phosphate 1fludarabine 1ferrous sulfate 1ferric gluconate 1epoetin beta 1enzalutamide 1entrectinib 1enasidenib 1durvalumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anemia × Hematopoietic Stem Cell Transplantation × Plasma cell × Clear all
NCT03303950 2022-05-05

Allogeneic Stem Cell Transplantation for Multiple Myeloma and Myelofibrosis

University of Utah

Phase 2 Terminated
6 enrolled 17 charts
Classical hematologyMyeloidPlasma cell

Anemia, Multiple Myeloma, Thrombocytopenia, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡